GSK plc(GLAXF)

Research Snapshot

GSK plc (GLAXF) is a Healthcare stock with a market cap of $76.99B and listed on OTC. The stock last traded around $25.33 and up 35.7% across the available one-year price window (Jun 30, 2025 → Jun 26, 2026). Baseline metrics include revenue growth of +4.1%, EPS growth of +123.8%, a dividend yield of 3.4%. What stands out right now is revenue +4.1%, EPS +123.8%, free cash flow +66.7% with operating margin 22.3% and ROIC 15.5%. The dividend matters to the case here, with a current yield around 3.4%. Valuation is more restrained than many high-expectation growth names at P/E 13.3 and price/sales 2.3. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines GLAXF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.